# Palonosetron

## Aloxi inj 0.25mg/5mL

#### 一般可用

| 藥品代碼       | IALO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:---------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Chemotherapy-induced nausea and vomiting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量       | Chemotherapy-induced nausea and vomiting， associated with emetogenic chemotherapy; Prophylaxis: Adult: 0.25 mg IV over 30 seconds approximately 30 minutes prior to starting chemotherapy. Children and Adolescents (1 month to 17 years old): 20 mcg/kg IV over 15 minutes approximately 30 minutes prior to starting chemotherapy; maximum dose: 1.5 mg.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 禁忌           | Hypersensitivity to palonosetron or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 副作用         | 1% to 10%: Cardiovascular: Prolonged Q-T interval on ECG (PONV 1% to 5%; chemotherapy-associated <1%)， bradycardia (chemotherapy-associated 1%)， sinus bradycardia (PONV: 1%)， tachycardia (may be nonsustained; 1%)， hypotension (<=1%) Central nervous system: Headache (chemotherapy-associated: Adults 9%; infants， children， and adolescents <1%)， anxiety (chemotherapy-associated: 1%)， dizziness (infants， children， adolescents， and adults ?1%) Dermatologic: Pruritus (PONV: 1%) Endocrine & metabolic: Hyperkalemia (chemotherapy-associated: 1%) Gastrointestinal: Constipation (chemotherapy-associated: 5%)， diarrhea (<=1%)， flatulence (<=1%) Genitourinary: Urinary retention (<=1%) Hepatic: Increased serum ALT (<=1%; may be transient)， increased serum AST (<=1%; may be transient) Neuromuscular & skeletal: Weakness (chemotherapy-associated: 1%) |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 哺乳期用藥建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

